Pharmaceutical

Building India Pharma Inc’s innovation muscle

While we agree that “what got us here (an affordable generics powerhouse) will ...

IPA hosts11th edition of Global Pharmaceutical Quality ...

Reportedly, 400+ delegates and 50 speakers were part of the summit The post IPA...

Traceability is your first line of defence

When patient safety is on the line, you need answers in minutes, not days. As s...

Asahi Kasei to acquire Aicuris Anti-infective Cures for...

The acquisition will expand the company’s speciality pharmaceutical platform int...

Quotient and Ipsen extend partnership for ultra-rare di...

FOP is an ultra-rare condition, impacting fewer than 1,000 people worldwide. The...

Lupin receives US FDA EIR with VAI classification for G...

Inspection conducted in November 2025; Establishment Inspection Report issued b...

Zenex Animal Health acquires majority stake in Netherla...

Transaction marks entry into global naturals market and sets up manufacturing a...

Lupin ranked among top 1% globally in S&P Global Corpor...

Company scores 91 out of 100; included in Sustainability Yearbook 2026 for thir...

Glenmark to launch Sodium Phosphates Injection USP sing...

Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million an...

GSK survey flags Shingles impact and prevention gaps am...

Findings released ahead of Shingles Action Week show low awareness and limited ...

IQVIA to acquire Charles River drug discovery assets

The acquisition includes five sites specialising in various in vitro drug discov...

Novo Nordisk and Vivtex collaborate for oral medicines ...

Vivtex will license to Novo Nordisk select oral drug-delivery technologies and i...

Eli Lilly India launches obesity awareness campaign

Initiative positions obesity as a chronic disease and highlights role of doctor...

Bayer secures India approval for expanded use of Nubeqa

Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data wi...

Alembic Pharmaceuticals receives USFDA approval for Lam...

Company secures final approval for ANDA across four strengths; cumulative USFDA...

MSD appoints Brecht Vanneste as MD for India

Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based...